Research ArticleTuberculosis

Targeting protein biotinylation enhances tuberculosis chemotherapy

See allHide authors and affiliations

Science Translational Medicine  25 Apr 2018:
Vol. 10, Issue 438, eaal1803
DOI: 10.1126/scitranslmed.aal1803

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • MTB L-forms suppression
    • Yuri Kalambet, Research scientist Biophysics, Statistics, Ampersand Ltd.

    Dear authors,
    There is no single word in your article about L-forms of MTB. Besides, this problem is strongly underestimated in current research. MTB possesses polymorphism, i.e. it can loose cell wall and convert in morphologically different, but genetically identical L-form under stress conditions. Investigations of this problem were conducted in Russia 40 years ago [1]. More recent research from Bulgarian team can be seen in [2]. Latent tuberculosis infection in vivo in most cases persists as L-form [1]. So, any investigation on suppression of MTB should check for influence of the drug on conversion of MTB in L-forms and influence on persistence of L-forms, as they may revert to classic MTB or cause another set of diseases such as endovasculitis or glomerulonephritis [3].
    Sincerely yours,
    Yuri Kalambet,
    PhD Biophysics
    Ampersand Ltd.
    Research scientist

    1. Zemskova ZS, Dorozhkova I. Latent Tuberculosis Infection (in Russian). Moscow: Meditsina; 1984
    2. Markova N, Slavchev G, Michailova L. Unique biological properties of Mycobacterium tuberculosis L-form variants: Impact for survival under stress. Int Microbiol. 2012;15(2):61-68. doi:10.2436/20.1501.01.159.
    3. Yakovleva G. Paratuberculous nephritis (in Russian). Clinical Medicine, 2002; 9:37-43

    Competing Interests: None declared.

Stay Connected to Science Translational Medicine

Navigate This Article